Objective: To explore the prognostic value of the postsurgical half-life (HL) of serum alpha-
fetoprotein (AFP). Background: There is still a paucity of early surrogate indicators of clinical …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

Introduction Although preoperative α-fetoprotein (AFP) has been recognized as an important
tumor marker among patients with hepatocellular carcinoma (HCC), the predictive value of …

Background While the majority of studies report that a raised serum α-fetoprotein (AFP) level
before operation is associated with a high risk of recurrence and death in patients who …

Abstract Background and Aim To study the change in serum alpha fetoprotein (AFP) of
patients with recurrent hepatocellular carcinoma (HCC) after curative resection and to …

Abstract Background/Aim: Alpha-fetoprotein (AFP) had been used as a prognostic factor in
hepatocellular carcinoma but it was unknown what level of AFP could predict the survival of …

AIM: To identify the clinical outcomes of hepatocellular carcinoma (HCC) patients with
inconsistent α-fetoprotein (AFP) levels which were initially high and then low at recurrence …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

We evaluated the clinical value of perioperative α-fetoprotein (AFP) and des-γ-carboxy
prothrombin (DCP) levels in predicting recurrence of hepatocellular carcinoma (HCC) after …